Microbot Medical Inc.

NASDAQ:MBOT

Medical - Instruments & Supplies

Healthcare
$0.98 -2.93%

-$0.06 today

Market cap
$65.73M
Beta
1.04
P/E (TTM)
-8.6
EPS (TTM)
-$0.21
52W Low $1.60High $4.67

Volume 0.87M

Average 1.60M

MBOT Operating Margin

Operating income as a percentage of revenue, showing the profitability of core operations.

Microbot Medical Inc.NASDAQ: MBOT

Operating Margin · Q1 FY2026 · quarter ended Mar 2026

Operating margin at -4114.3%

Operating margin was -4114.3% in Q1 FY2026. On a trailing-twelve-month basis it was -15278.1%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
-4114.3%— QoQ
Last fiscal yearDec 2025
—— YoY
LTMMar 2026
-15278.1%— YoY
Operating Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3 years———
5 years——
10 years——

Operating Margin history

Percent of revenue · from the income statement

No Operating Margin data reported for this period type.

Operating Margin vs competitors

How MBOT compares with its peers on the latest reported figures

  • MBOT's LTM Mar 2026 operating margin of -15278.1% is the 6th highest of the 7 companies compared; the peer median is -712.3%.
MBOT Competitors Peer median
Operating Margin for MBOT and competitors
Company Period LTM level YoY 3-year change
DCGODocGo Inc.LTM Mar 2026-36.7% -36.4 pp-32.6 pp
RCELAVITA Medical, Inc.LTM Mar 2026-54.6% +16.9 pp+21.3 pp
OVIDOvid Therapeutics Inc.LTM Mar 2026-670.2% +9733.9 pp+3111.2 pp
ORMPOramed Pharmaceuticals Inc.FY2025-754.4% —+747.6 pp
ZTEKZentek Ltd.LTM Mar 2026-6325.9% -5225.5 pp+13590.8 pp
MBOTMicrobot Medical Inc.LTM Mar 2026-15278.1% ——
CLNNClene Inc.LTM Mar 2026-15535.1% -7553.1 pp-1307.0 pp
CRDLCardiol Therapeutics Inc.FY2025— ——
VANIVivani Medical, Inc.FY2025— ——
CNTXContext Therapeutics Inc.FY2025— ——
Peer median (excluding MBOT) -712.3%-36.4 pp+384.5 pp

Competitors are the stored peer set for MBOT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue00106K91K0
Gross Profit00(106K)(91K)0
Gross Margin—————
Research & Development6.15M7.74M5.72M6.63M6.28M
Selling, General & Admin5.41M5.58M4.13M5M8.25M
Operating Expenses11.36M13.28M9.75M11.53M14.74M
Depreciation & Amortization76K102K106K91K47K
EBITDA(11.24M)(13.34M)(10.63M)(11.35M)(13.1M)
EBITDA Margin—————
Operating Income(11.36M)(13.28M)(9.86M)(11.63M)(14.74M)
Operating Margin—————
Interest Income44K54K228K182K1.29M
Interest Expense00000
Other Income / Expenses44K113K(885K)182K1.6M
Income Before Tax(11.31M)(13.17M)(10.74M)(11.44M)(13.14M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(11.31M)(13.17M)(10.74M)(11.44M)(13.14M)
Net Margin—————
EPS (Basic)(1.59)(1.81)(1.05)(0.73)(0.29)
EPS (Diluted)(1.59)(1.81)(1.05)(0.73)(0.29)
Weighted Avg Shares7.11M7.26M10.2M15.65M45.79M
Weighted Avg Shares (Diluted)7.11M7.26M10.2M15.65M45.79M

Microbot Medical Inc.

NASDAQ:MBOT

Intrinsic Alpha fair value

Locked

Current Price

$0.98

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.